✦ LIBER ✦

Prognosis and prognostic factors for patients with chronic myeloid leukemia: Nontransplant therapy

✍ Scribed by J. Hasford; M. Pfirrmann; R. Hehlmann; M. Baccarani; F. Guilhot; F.X. Mahon; H.C. Kluin-Nelemans; K. Ohnishi; J. Thaler; J.L. Steegmann

Book ID: 117211347
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 132 KB
Volume: 40
Category: Article
ISSN: 1532-8686
DOI: 10.1016/s0037-1963(03)70038-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Optimizing First-Line Therapy for Patien

Optimizing First-Line Therapy for Patients With Chronic Myeloid Leukemia

✍ Carmen Fava; Jorge Cortes 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 436 KB

Prognostic factors at relapse for adults

Prognostic factors at relapse for adults with acute myeloid leukemia

✍ Dorothy L. Uhlman; Clara D. Bloomfield; David D. Hurd; Bruce A. Peterson 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 611 KB

Biological therapy and the immune system

Biological therapy and the immune system in patients with chronic myeloid leukemia

✍ Rohon, Peter 📂 Article 📅 2012 🏛 Carden Jennings Publishing 🌐 English ⚖ 303 KB

Prognostic significance of Tie-1 protein

Prognostic significance of Tie-1 protein expression in patients with early chronic phase chronic myeloid leukemia

✍ Srdan Verstovsek; Hagop Kantarjian; Taghi Manshouri; Susan O'Brien; Stefan Fader 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 2 views

Therapy-related myelodysplastic syndrome

✍ M. Čolović; N. Suvajdžić; G. Janković; D. Tomin; N. Čolović; M. Denčić Fekete; V 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 154 KB

The prognosis for patients with chronic

The prognosis for patients with chronic myeloid leukemia who have clonal cytogenetic abnormalities in philadelphia chromosome-negative cells

✍ Michael W. N. Deininger; Jorge Cortes; Ron Paquette; Byung Park; Andreas Hochhau 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 380 KB

## Abstract ## BACKGROUND. Clonal cytogenetic abnormalities (CCA) were detected in Philadelphia chromosome (Ph)‐negative cells in some patients with chronic myeloid leukemia (CML) who attained a cytogenetic response to imatinib mesylate. In some patients, CCA/Ph‐negative status was associated with